SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+9.74%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$554M
AUM Growth
+$554M
(-2.4%)
Cap. Flow
-$70.7M
Cap. Flow
% of AUM
-12.76%
Top 10 Holdings %
Top 10 Hldgs %
48.85%
Holding
147
New
23
Increased
32
Reduced
53
Closed
29
Top Buys
| 1 |
Ormat Technologies
ORA
|
$19.9M |
| 2 |
Pfizer
PFE
|
$19.5M |
| 3 |
Biogen
BIIB
|
$11.9M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$5.76M |
| 5 |
Opko Health
OPK
|
$5.03M |
Top Sells
| 1 |
Elbit Systems
ESLT
|
$29.2M |
| 2 |
SHPG
Shire pic
SHPG
|
$26.6M |
| 3 |
AGN
Allergan plc
AGN
|
$24.1M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$12.7M |
| 5 |
Viatris
VTRS
|
$8.05M |
Sector Composition
| 1 | Healthcare | 74.78% |
| 2 | Utilities | 7.14% |
| 3 | Technology | 2.29% |
| 4 | Consumer Discretionary | 1.7% |
| 5 | Communication Services | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
26
DELISTED
Radius Health, Inc.
RDUS
| $4.31M | 0.63% | +70,000 | New | +$4.31M |
|
27
Vanda Pharmaceuticals
VNDA
$279M
| $4.3M | 0.63% | 462,051 -51,339 | -10% | -$478K |
|
|
ADMS
28
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $4.25M | 0.62% | +150,000 | New | +$4.25M |
|
29
Rocket Pharmaceuticals
RCKT
$354M
| $4.08M | 0.6% | 360,000 +65,000 | +22% | +$736K |
|
30
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.77M | 0.55% | 40,000 | – | – |
|
|
ALDR
31
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $3.72M | 0.54% | 112,500 -12,500 | -10% | -$413K |
|
|
ORBK
32
DELISTED
Orbotech Ltd
ORBK
| $3.71M | 0.54% | 167,619 +89,137 | +114% | +$1.97M |
|
33
Zevra Therapeutics
ZVRA
$509M
| $3.65M | 0.53% | 183,954 -20,439 | -10% | -$406K |
|
34
Heron Therapeutics
HRTX
$207M
| $3.61M | 0.53% | 135,000 +85,000 | +170% | +$2.27M |
|
35
Acadia Pharmaceuticals
ACAD
$4.38B
| $3.57M | 0.52% | +100,000 | New | +$3.57M |
|
36
Catalyst Pharmaceutical
CPRX
$2.52B
| $3.57M | 0.52% | 1,455,000 +355,000 | +32% | +$870K |
|
|
RPTP
37
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $3.56M | 0.52% | 685,000 +100,911 | +17% | +$525K |
|
38
Bausch Health
BHC
$2.74B
| $3.43M | 0.5% | 33,750 +18,000 | +114% | +$1.83M |
|
|
CNCE
39
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.42M | 0.5% | 180,000 -20,000 | -10% | -$379K |
|
40
TJX Companies
TJX
$152B
| $3.4M | 0.5% | 47,961 +6,465 | +16% | +$458K |
|
|
ANAC
41
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $3.39M | 0.5% | 30,000 +20,000 | +200% | +$2.26M |
|
|
KDNY
42
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.38M | 0.49% | +120,000 | New | +$3.38M |
|
43
Novavax
NVAX
$1.21B
| $3.36M | 0.49% | 400,000 +250,000 | +167% | +$2.1M |
|
|
TVRD
44
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $3.34M | 0.49% | 197,820 -21,980 | -10% | -$371K |
|
|
CLVS
45
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.31M | 0.48% | 94,500 -10,500 | -10% | -$368K |
|
46
Agios Pharmaceuticals
AGIO
$2.19B
| $3.25M | 0.48% | +50,000 | New | +$3.25M |
|
|
EGLT
47
DELISTED
Egalet Corporation
EGLT
| $3.22M | 0.47% | 292,500 -32,500 | -10% | -$358K |
|
|
SGEN
48
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.14M | 0.46% | 70,000 +20,000 | +40% | +$898K |
|
|
KITE
49
DELISTED
Kite Pharma, Inc.
KITE
| $3.08M | 0.45% | 50,000 -6,970 | -12% | -$429K |
|
50
Mondelez International
MDLZ
$79.5B
| $3.08M | 0.45% | 68,625 +9,150 | +15% | +$410K |
|